Morgan Stanley Lowers its Price Target on IQVIA Holdings Inc. (IQV) to $240 but Maintains an Overweight Rating

NodeGuardian · 2026-03-13T14:50:05+00:00

Morgan Stanley reduced its price target for IQVIA Holdings Inc. to $240 but kept an Overweight rating after solid Q4 results. IQVIA posted revenues of $4.36 billion, surpassing estimates, and announced a collaboration with Duke Clinical Research Institute in obesity research.

NodeGuardian

2026-03-13 14:50:05

Geração de resumo em curso

Morgan Stanley has lowered its price target for IQVIA Holdings Inc. (IQV) to $240 from $265 but maintained an Overweight rating following IQVIA’s strong fourth-quarter results. The company also announced a new collaboration with Duke Clinical Research Institute to advance clinical research in obesity. IQVIA reported revenues of $4.36 billion, exceeding estimates, and showed strong performance across segments, driven by expanded market efforts, operational discipline, and AI investments.

Esta página pode conter conteúdos de terceiros, que são fornecidos apenas para fins informativos (sem representações/garantias) e não devem ser considerados como uma aprovação dos seus pontos de vista pela Gate, nem como aconselhamento financeiro ou profissional. Consulte a Declaração de exoneração de responsabilidade para obter mais informações.